Please sign in to follow a disease.
VR gaming eases long COVID pain and fatigue, study finds
NCT ID NCT04983394
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether motion-controlled video games in virtual reality could help people with long COVID feel better. 79 participants either played VR games or did standard exercises. Researchers measured pain, fatigue, mood, and quality of life to see if the VR approach was more effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- motion-controlled video game-based virtual reality exercises
- What this could lead to
- If it works, this could offer a fun, accessible way to manage lingering COVID-19 symptoms like pain and fatigue.
- What could go wrong
- This is a small, completed study with 79 participants, so results may not apply to everyone. The intervention is not a cure and only targets symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
79 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Feb 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosed with COVID-19 by polymerase chain reaction from an oropharyngeal or nasopharyngeal swab sample more than 90 days ago, and who had PCC symptoms for at least eight weeks Exclusion Criteria: * have been hospitalized due to COVID-19, * have developed pneumonia or organ failure findings. * have had an acute myocardial infarction in the last 2 years, * have cardiovascular system disease such as uncontrolled hypertension, arrhythmia, aneurysm, cardiac failure, * have undergone fracture or orthopedic surgery in the last 2 years, * have a known chronic respiratory system disease, * have widespread pain such as fibromyalgia syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sivas Cumhuriyet University
Sivas, 58050, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home antibody tests put to the test: can you read your own COVID-19 result?
- COVID-19's hidden toll: muscle wasting in the ICU
- Can a mild case of COVID-19 harm your kidneys? urine tests may hold the answer
- Could a common acne pill weaken the nose's defense against COVID-19?
- Could cystic fibrosis offer hidden protection against COVID-19?
- Can magnetic pulses to the brain reverse Long-COVID smell loss, tinnitus, and fatigue?